Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Amphotericin B recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Amphotericin B (17 total). Check the affected lots below.

Most common reason: Labeling / mix-up (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Amphotericin B. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Amphotericin B recalls on record

none so far in 2026; 17 on record, newest first
Class II · Moderate risk

Amphotericin B active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-521-2015
Class II · Moderate risk

AmBisome (amphotericin B)

Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.

Terminated Microbial contamination Gilead Sciences, Inc. NDC 0469-3051-30 D-821-2013
Class II · Moderate risk

AmBisome (amphotericin B)

Lack of Assurance of Sterility; Astellas Pharma US, Inc. is performing a voluntary recall on certain lots of AmBisome because the manufacturer has notified Astellas that during a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in the media fills.

Terminated Microbial contamination Astellas Pharma US Inc D-820-2013
Class II · Moderate risk

Amphotericin B Ophthalmic

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1456-2012
Class II · Moderate risk

Tobramycin 1.4%

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1627-2012